Impact of maternal use of asthma-controller therapy on perinatal outcomes

Thorax

Volumn 68, Issue 8, 2013, Pages 724-730

  Cossette, Benoit ^a,b   Forget, Amélie ^a,c   Beauchesne, Marie France ^a,b,d   Rey, Évelyne ^a,e   Lemière, Catherine ^a,c   Larivée, Pierre ^d,f   Battista, Marie Claude ^d,f   Blais, Lucie ^a,c,d  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^c HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^d Centre Hospitalier Universitaire de Sherbrooke   (Canada)

^e UNIVERSITY OF MONTREAL   (Canada)

^f UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG;

ADULT; ARTICLE; ASTHMA; CANADA; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE CONTROL; DOSE RESPONSE; DRUG EXPOSURE; DRUG MEGADOSE; DRUG SAFETY; FEMALE; GESTATION PERIOD; HUMAN; LOW BIRTH WEIGHT; LOW DRUG DOSE; PERINATAL PERIOD; PREGNANCY OUTCOME; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; SMALL FOR DATE INFANT; TREATMENT OUTCOME;

ASTHMA; CLINICAL EPIDEMIOLOGY;

ADMINISTRATION, INHALATION; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MALE; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; PREVALENCE; QUEBEC; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84879898801     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-203122     Document Type: Article

References (31)

1. Kwon HL, Triche EW, Belanger K, et al. The epidemiology of asthma during pregnancy: prevalence, diagnosis, and symptoms. Immunol Allergy Clin North Am 2006;26:29-62. (Pubitemid 43144610)
2. Bakhireva LN, Schatz M, Jones KL, et al. Asthma control during pregnancy and the risk of preterm delivery or impaired fetal growth. Ann Allergy Asthma Immunol 2008;101:137-43.
3. From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2011. http://www.ginasthma.org/ (accessed 21 Dec 2012).
4. Murphy VE, Clifton VL, Gibson PG. Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax 2006;61:169-76. (Pubitemid 43235435)
5. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. J Allergy Clin Immunol 2005;115:34-46.
6. National Heart Lung and Blood Institute. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (2007). http://www.nhlbi.nih.gov/guidelines/ asthma/ (accessed 29 Aug 2012).
7. Bracken MB, Triche EW, Belanger K, et al. Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies. Obstet Gynecol 2003;102:739-52. (Pubitemid 37206410)
8. Clifton VL, Rennie N, Murphy VE, et al. Effect of inhaled glucocorticoid treatment on placental 11beta-hydroxysteroid dehydrogenase type 2 activity and neonatal birthweight in pregnancies complicated by asthma. Aust N Z J Obstet Gynaecol 2006;46:136-40.
9. Alexander S, Dodds L, Armson BA. Perinatal outcomes in women with asthma during pregnancy. Obstet Gynecol 1998;92:435-40. (Pubitemid 28396872)
10. Bakhireva LN, Jones KL, Schatz M, et al . Asthma medication use in pregnancy and fetal growth. J Allergy Clin Immunol 2005;116:503-9. (Pubitemid 41267119)
11. Dombrowski MP, Schatz M, Wise R, et al. Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy. Am J Obstet Gynecol 2004;190:737-44. (Pubitemid 38406786)
12. Hodyl NA, Stark MJ, Osei-Kumah A, et al. Fetal glucocorticoid-regulated pathways are not affected by inhaled corticosteroid use for asthma during pregnancy. Am J Respir Crit Care Med 2011;183:716-22.
13. Hodyl NA, Wyper H, Osei-Kumah A, et al. Sex-speci fic associations between cortisol and birth weight in pregnancies complicated by asthma are not due to differential glucocorticoid receptor expression. Thorax 2010;65:677-83.
14. Namazy J, Schatz M, Long L, et al. Use of inhaled steroids by pregnant asthmatic women does not reduce intrauterine growth. J Allergy Clin Immunol 2004;113:427-32. (Pubitemid 38338945)
15. Schatz M, Dombrowski MP, Wise R, et al. The relationship of asthma medication use to perinatal outcomes. J Allergy Clin Immunol 2004;113:1040-5. (Pubitemid 38857982)
16. Schatz M, Zeiger RS, Harden K, et al. The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol 1997;100:301-6. (Pubitemid 27402770)
17. Kramer MS, Platt RW, Wen SW, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001;108:E35.
18. Lee PA, Chernausek SD, Hokken-Koelega ACS, et al. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age. Pediatrics 2003;111:1253-61. (Pubitemid 36682257)
19. Blais L, Beauchesne MF, Rey E, et al. Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma. Thorax 2007;62:320-8. (Pubitemid 46580575)
20. Martel MJ, Rey E, Beauchesne MF, et al. Use of short-acting beta-agonists during pregnancy and the risk of pregnancy-induced hypertension. J Allergy Clin Immunol 2007;119:576-82.
21. Firoozi F, Lemiere C, Beauchesne M-F, et al . Development and validation of database indexes of asthma severity and control. Thorax 2007;62:581-7. (Pubitemid 47056883)
22. Schneeweiss S, Glynn RJ, Tsai EH, et al. Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Epidemiology 2005;16:17-24. (Pubitemid 40239274)
23. Institut de la statistique du Québec. Naissances selon la durée de la grossesse et le poids à la naissance, Québec, 1980-2009. http://www.stat.gouv.qc.ca/donstat/societe/demographie/naisn-deces/ naissance/418.htm (accessed 29 Aug 2012).
24. Murphy VE, Namazy JA, Powell H, et al. A meta-analysis of adverse perinatal outcomes in women with asthma. BJOG 2011;118:1314-23.
25. Murphy VE, Zakar T, Smith R, et al. Reduced 11beta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma. J Clin Endocrinol Metab 2002;87:1660-8. (Pubitemid 34615254)
26. Jana N, Vasishta K, Saha SC, et al. Effect of bronchial asthma on the course of pregnancy, labour and perinatal outcome. J Obstet Gynaecol 1995;21:227-32.
27. Firoozi F, Lemiere C, Ducharme FM, et al. Effect of maternal moderate to severe asthma on perinatal outcomes. Respir Med 2010;104:1278-87.
28. Firoozi F, Lemière C, Beauchesne M-F, et al. Impact of maternal asthma on perinatal outcomes: a two-stage sampling cohort study. Eur J Epidemiol 2012;27:205-14.
29. Bloom S, Sheffield J, McIntire D, et al. Antenatal dexamethasone and decreased birth weight. Obstet Gynecol 2001;97:485-90.
30. Powell H, Murphy VE, Taylor DR, et al. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. Lancet 2011;378:983-90.
31. Lougheed MD, Lemiere C, Ducharme FM, et al. Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J 2012;19:127-64.